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Synopsis 
Occasionally, crystallisation of proteins works in mysterious ways!  One might obtain 
crystals of a protein of unknown identity in place of the protein for which crystallisation 
experiments were performed.  If the investigator is not aware of such possibilities, 
valuable time and resources might be lost in attempting to determine the structure of such 
proteins.  Instances of non-target protein getting crystallised may not come to light at all 
or may be realised only when attempts to determine the structure completely fail by 
conventional procedures after collecting and processing the diffraction data.  Usually, it is 
not possible to reproduce the crystals of the same protein as their occurrence is 
serendipitous. Such rare instances of crystallisation are probably caused by fluctuating 
environmental or crystallisation conditions and are not reproducible.  It could also be due 
to contaminating microbes, which is more likely when the experimentalist is not well 
experienced.  Therefore, experimental phasing of the data collected on serendipitously 
obtained crystals could be a challenging task. 
With the rapid increase in the number of structures deposited in the protein data bank 
(PDB), molecular replacement has become the method of choice for structure 
determination in macromolecular X-ray crystallography. This is due to the fact that it is 
possible to select a suitable phasing model for most target proteins based on their 
sequence information.  However, if the identity of the target protein itself is uncertain, all 
attempts of structure determination using phasing models selected on the basis of target 
protein sequence-dependent search would fail.  Sequence-independent ab initio phasing 
techniques such as ARCIMBOLDO (Meindl et al., 2012), which has recently become 
available, could provide leads only if the non-target protein is an all-α-protein and the 
associated diffraction data extends to a resolution better than 2 Å.  Even then, the success 
rate with this technique is low. Hence, it becomes important to employ a sequence-
independent method of structure determination for such mysteriously obtained crystals. 
This thesis reports crystal structures of proteins which are serendipitously crystallised 
using a large-scale application of Molecular Replacement (MR) technique (referred in 
this thesis as MarathonMR). This thesis also presents an evaluation of molecular 
replacement strategies for structure determination. 
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The thesis begins with an overview of crystallographic methods of structure 
determination with an emphasis on the method of molecular replacement (Chapter 1).  
The most prominent of the results obtained in the course of these investigations pertains 
to a crystal obtained during routine crystallisation of a viral protein mutant in the year 
2011.  The cell parameters were different from cell constants of crystals obtained with 
other known viral protein mutants crystallised earlier in the same laboratory.  
Unfortunately, this crystal could not be reproduced in the same form in subsequent 
crystallisation trials.  All attempts to determine the structure through conventional 
molecular replacement techniques using a combination of domains from a nearly identical 
virus coat protein protomer as the phasing model had failed.   The data was shelved as 
“not-solvable” in late 2011.  However, the crystal had diffracted to 1.9 Å and had 
excellent merging statistics.  Therefore, the data was retrieved recently and additional 
attempts were made to determine the structure through phasing techniques that have 
become available recently.  Techniques such as AMPLE (Bibby et al., 2013) and Rosetta 
(DiMaio, 2013), which use large-scale homology models coupled with molecular 
replacement, did not lead to meaningful solutions.  A couple of helices identified by 
ARCIMBOLDO (Meindl et al., 2012) were neither correct (retrospectively) nor sufficient 
to determine the entire structure.  Given the excellent merging statistics of the crystal 
data, there was significant motivation to determine the structure, though it meant 
developing a fresh protocol.  It was at this time that we came across the work of Stokes-
Rees and Sliz (2010) in which they had demonstrated that it is possible to determine 
structure of proteins of unknown identity by employing almost every known protein 
structure as a potential phasing model. 
The work reported in the thesis is a result of an earlier project to examine the relationship 
between properties of phasing models and the quality of target protein model generated 
through MR by employing large scale molecular replacement runs. This project was 
initiated because of the realisation that the recent explosion in crystallographic structural 
studies has resulted in near complete exploration of the “fold-space” of proteins and PDB 
now has a representative structure for most plausible folds of proteins. Some folds are 
highly represented in the PDB.  Hence, it is likely that there would be at least one 
homologue in the PDB which could be used as a phasing model to successfully determine 
the structure of a protein of unknown identity if the diffraction dataset is of excellent 
quality.  Hence, the single dataset which had diffracted to 1.9 Å resolution was used to 
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develop a MarathonMR procedure for structure determination.  MarathonMR procedure 
takes sequence-independent approach to structure determination and employs large-scale 
molecular replacement calculations to identify the closest homologue (in structural terms 
initially).  This protocol is described in Chapter 2 (Materials and methods) of the thesis.  
Through MarathonMR, structure of the dataset which had remained unsolved for 5 years 
was finally determined.  Nearly complete sequence of the polypeptide could be deduced 
by inspecting the electron density map due to the high resolution and quality of the map. 
The protein was found to be a phosphate binding protein from a soil bacterium 
Stenotrophomonas maltophilia (SmPBP).  The way in which the structure was determined 
and possible explanations for the mysterious source of this protein which had crystallised 
instead of the target protein is discussed in Chapter 3.  Though MarathonMR procedure 
was developed to solve a single dataset, it was soon realised that the same procedure 
could be applied to other similar datasets, all of which had diffracted to reasonable 
resolutions with good merging statistics but had remained unsolved for unknown reasons.  
Among such datasets, one of the datasets which was collected in 2007 and had diffracted 
to 2.3 Å resolution had cell parameters very close to that of SmPBP.  Hence, a poly-
alanine model of the structure of SmPBP, which was determined by then, was used as the 
phasing model to run molecular replacement and the structure was readily solved.  It was 
surprising to note that SmPBP had crystallised serendipitously not once but twice, once in 
2011 resulting in crystals that diffracted to 1.9 Å resolution and earlier in 2007 in crystals 
that diffracted to 2.3 Å resolution independently by two different investigators in the 
same laboratory.  Both the structures are nearly identical and a comparison of these 
structures is presented in Chapter 4.  Structure of SmPBP determined at 2.3 Å resolution 
by MarathonMR also corresponds to the dataset that had remained unsolved for the 
longest period of time (9 years). This success of structure determination after the lapse of 
such a long period emphasises the importance of carefully preserving X-ray diffraction 
data irrespective of its immediate outcome. 
In Chapter 5 of the thesis, another instance of non-target protein crystallisation, the 
structure of which was determined using the MarathonMR procedure is described.  The 
crystal was obtained while carrying out crystallisation of mutants of a survival protein 
(SurE) expressed in Salmonella typhimurium when the bacterium is subjected to 
environmental or internal stresses. The original investigator had used the structure of 
SurE as the phasing model to determine structure of the mutant crystals and obtained a 
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model with R and Rfree of 35% and 40%, respectively.  However, the model did not 
refine further to lower R-factors suggesting that the solution obtained may not be correct.  
MarathonMR indicated that the fold of the crystallised protein could be similar to that of 
glycerol dehydrogenase.  As SurE shares some fold similarity with one of the domains of 
GlyDH, the original investigator might have been able to achieve a limited success with 
R/Rfree factors of 35% and 40%, respectively.  As the merging statistics for this 
diffraction data set was poor, the diffraction images were reprocessed in XDS program on 
Xia2 automated spot processing pipeline.  The data statistics indicated merohedral 
twinning (14%).  However, using appropriate parameters, it was possible to refine the 
structure obtained by MarathonMR to acceptable R/Rfree using the Refmac program.  
Four protomers were present in the crystal asymmetric unit (ASU). Non-crytsallographic 
symmetry averaging of electron density over these four molecules further improved the 
electron density.  As the data was limited to 2.7 Å resolution, it was not possible to 
deduce the identity of every residue of the protein unambiguously based solely on the 
resulting electron density map.  With the identity of the amino acids that could be 
deduced with certainty, it was clear that the protein belongs to glycerol dehydrogenase 
from a species of Enterobacteriacea family.  Though a similar structure of glycerol 
dehydrogenase has been reported from Serratia, there are clear differences in many 
unambiguously determined residues which suggest that the protein is not from Serriatia.  
The protein has been named EnteroGlyDH as the source of the protein is likely to be from 
a species of Enterobacteriacea family. The structure of the protein, its biochemical 
implications and possible reasons for the serendipitous crystallisation of a non-target are 
discussed. 
Chapter 6 discusses the structure determination of an inorganic pyrophosphatase and 
catalytic domain of Succinyl transferase, the crystals of which had diffracted to 2.3 Å and 
3.1 Å, respectively, but had remained unsolved.  Neither of the datasets corresponds to 
the intended target proteins. The dataset corresponding to the protein whose structure was 
determined as that of an inorganic pyrophosphatase was provided by a colleague from a 
different laboratory in the Indian Institute of Science.  It is interesting to note that the 
investigator had carried this dataset to one of the CCP4 workshops and had tried to 
determine the structure with the help of experts in the workshop. The attempts to 
determine its structure had however failed for reasons that are obvious now.  The original 
investigator was unfortunately making efforts with an erroneous assumption on the 
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identity of the target protein. As these enzymes are well studied, their structures and 
functions are briefly discussed. 
It is already well established that molecular replacement is being used with increasing 
frequency as the phasing technique when compared to other experimental phasing 
techniques.  With the ever growing number of structures in the PDB, high population of 
certain folds and a near-plateau attained in the identification and growth of new folds, it is 
reasonable to expect that molecular replacement will be used even more frequently in the 
years to come.  Therefore, for carrying out molecular replacement for a given diffraction 
dataset of a target protein, it is very likely that several homologous structures would be 
available in the PDB that could be used as potential phasing models.  Hence, it becomes 
important to understand the influence of phasing model on the quality and accuracy of 
model generated through MR to achieve the best structure solution.  To understand this 
relationship between phasing model and model obtained by MR protocol, re-
determination of already known structures deposited in the PDB starting with their 
respective structure factors and various phasing models was initiated.  Structures 
belonging to TIM beta/alpha-barrel (SCOPe ID: c.1) and Lysozyme-like (SCOPe ID: d.2) 
folds were chosen as targets.  The structure of each target was re-determined serially 
starting with poly-alanine models of all available unique homologues as phasing models.  
Due to the multi-dimensional nature of this study, the results obtained were represented in 
a graphical form with nodes and edges.  Detailed methodology of the work carried out 
and the data representation model are discussed in the Chapter 2 (Materials and methods).  
It was found that after a certain sequence identity cut-off, sequence identity between 
phasing model and target seems to have little influence on the quality and accuracy of the 
model generated through MR.  Instead, other qualities of the phasing model such as Rfree 
and RSCC influence the quality of MR models.  These results are discussed in Chapter 7.  
Learning from the work reported in this thesis are discussed in concluding chapter. The 
possible logical and programmatic upgrades to MarathonMR protocol and future path in 
which the relationship between phasing models and models generated through MR can be 
studied are discussed in Chapter 8 (Conclusion and future prospects). 
